Clinical trials
Active, not recruiting Phase 2 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aphaia Pharma US LLC | 1 |
| AstraZeneca | 1 |
| Corcept Therapeutics | 1 |
| Douglas Seals | 1 |
| Herlev and Gentofte Hospital | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
| Rong Zhang | 1 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 11 |
| Renal Insufficiency, Chronic | 2 |
| ACTH Syndrome, Ectopic | 1 |
| Adrenal Cortex Neoplasms | 1 |
| Adrenocortical Carcinoma | 1 |
| Alzheimer Disease | 1 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Cushing Syndrome | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.